Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

EBMT 2022 | Shared treatment decision-making

Jana Pelouchová • 22 Mar 2022

EBMT 2022

General

Jana Pelouchová, Diagnoza leukemie, Prague, Czech Republic, talks on shared treatment decision-making in hematological oncology. Ms Pelouchová explains that patients are becoming increasingly interested in understanding their condition and available treatment options However, there are still many patients who are not aware of their exact diagnosis and the treatment they are receiving. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.

The voice of patient advocacy organisations among healthcare stakeholders in Czech Republic

Jana Pelouchová • 22 Mar 2022

Patient access to therapies in Central and Eastern Europe

Jana Pelouchová • 22 Mar 2022

Related Videos

Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD

Florent Malard • 11 Apr 2024

Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD

Mohamad Mohty • 17 Apr 2024

HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors

Rémy Duléry • 15 Apr 2024

The consequences of regulatory changes on access to devices and reagents needed for graft processing

Christian Chabannon • 16 Apr 2024